Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, Inc. (MPLT), sold 147,639 shares at $36.00 ($5.4M) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Open-market sale of $5.4M MPLT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.00 | 18,950 | $682K | 12.5% |
| 2 | $36.99 | 42,738 | $1.6M | 29.0% |
| 3 | $37.54 | 90 | $3K | 0.1% |
| 4 | $36.46 | 40,899 | $1.5M | 27.4% |
| 5 | $37.26 | 28,091 | $1.0M | 19.2% |
| 6 | $37.96 | 92 |
| $3K |
| 0.1% |
| 7 | $37.90 | 16,779 | $636K | 11.7% |
| Total | $36.87 avg | 147,639 | $5.4M | 100% |
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.4M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $521K | — | Filing → |